[Venous thromboembolic disease].
Prevention and treatment of venous thrombosis and pulmonary embolism have improved dramatically in the last few years owing to: 1) better control of the coumarin activity with the International Normalized Ratio system; 2) appearance on the market of the low-weight molecular heparins and enlargement of their field of prescription; 3) indications of thrombolysis in severe pulmonary embolism; 4) availability of inferior vena cava filters, effective in preventing recurrent pulmonary embolism.
Service de Médecine Interne, Hôpital Erasme, Bruxelles.
J
J
Sternon
D000925:Anticoagulants / Q000627:therapeutic use; D017128:Embolectomy; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D011186:Postphlebitic Syndrome / Q000517:prevention & control; D011655:Pulmonary Embolism / Q000209:etiology / Q000628:therapy; D013923:Thromboembolism / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D015912:Thrombolytic Therapy
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight